| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| beloranib | methionine aminopeptidase 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Obesity[MeSHID:D009765] |
63.65 | phase 3 | inhibitor |
| beloranib | methionine aminopeptidase 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Obesity[MeSHID:D009765] |
63.65 | phase 3 | unknown |
| click here to return to the previous page | ||||||||